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SCIENTIFIC OPINION 
Scientific Opinion on the annual post-market environmental monitoring 
(PMEM) report from Monsanto Europe S.A. on the cultivation of 
genetically modified maize MON 810 in 2012
1 
EFSA Panel on Genetically Modified Organisms (GMO)
2,3 
European Food Safety Authority (EFSA), Parma, Italy 
ABSTRACT 
Following a request from the European Commission, the Panel on Genetically Modified Organisms of the 
European Food Safety Authority (EFSA GMO Panel) assessed the post-market environmental monitoring 
(PMEM) report for the 2012 growing season of maize MON 810 provided by Monsanto Europe S.A. The EFSA 
GMO Panel noted that the applicant used a similar methodology as the one previously established for monitoring 
maize MON 810 in 2009, 2010 and 2011. The EFSA GMO Panel therefore focused its assessment on the novel 
datasets specific to the 2012 growing season of maize MON  810, and not on the methodology. The data 
submitted by the applicant in its 2012 PMEM report do not indicate any adverse effects on human and animal 
health or the environment arising from maize MON  810 cultivation in 2012. However, having already 
highlighted the poor sensitivity of the methodology followed by the applicant, the EFSA GMO Panel strongly 
reiterates its previous recommendations for the improvement of the methodology. In addition, the EFSA GMO 
Panel recommends that the applicant: (1) further investigates effects observed during the monitoring of baseline 
susceptibility of target pests in Spain; (2) follow-up possible adverse effects of maize MON 810 on rove beetles. 
© European Food Safety Authority, 2014 
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SUMMARY 
Following a request from the European Commission, the Panel on Genetically Modified Organisms of 
the European Food Safety Authority (EFSA GMO Panel) assessed the post-market environmental 
monitoring (PMEM) report for the 2012 growing season of maize MON 810 provided by Monsanto 
Europe S.A. 
The EFSA GMO Panel firstly noted that the applicant followed a similar methodological approach for 
both Case-Specific Monitoring (CSM) and General Surveillance (GS) of maize MON 810 as in its 
previous PMEM reports. Subsequently, considering the unchanged methodology for PMEM of maize 
MON 810 in 2012, the EFSA GMO Panel focused its assessment on the novel datasets specific to the 
2012 growing season of maize MON 810 (i.e. data from monitoring changes in baseline susceptibility 
of target pests, farmer questionnaires, information on refugia compliance in Spain and Portugal, and 
outcomes of the literature review). These data, submitted by the applicant in its 2012 PMEM report, 
do not indicate any adverse effects on human and animal health or the environment arising from maize 
MON 810 cultivation in 2012. 
However, the sensitivity of the methodology is still considered too low for an early detection of 
possible adverse effects. Hence, the Panel’s previous recommendations for improvement of the 
PMEM of maize MON 810 are repeated, in particular the recommendation for annual sampling of 
both target pests in areas of high maize MON 810 adoption rate. 
In addition, the EFSA GMO Panel recommends that the applicant: (1) further investigates effects 
observed during the monitoring of baseline susceptibility of target pests in Spain; (2) follow-up 
possible adverse effects of maize MON 810 on rove beetles. Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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BACKGROUND AS PROVIDED BY THE EUROPEAN COMMISSION AND EFSA 
The placing on the market for cultivation of maize MON 810 in the EU is authorised since 1998 
through Commission Decision 98/294/EC of 22 April 1998 (EC, 1998) and the consent granted on 3 
August 1998 by the Competent Authority of France. 
Following the request by the applicant for the renewal of the authorisation for placing maize 
MON 810 on the market, the EFSA GMO Panel adopted a scientific opinion on the renewal under 
Regulation (EC) No 1829/2003 of maize MON 810 for import, processing for food & feed uses and 
cultivation in June 2009 (EFSA, 2009). The EFSA GMO Panel concluded that “maize MON 810 is 
unlikely to have any adverse effect on the environment in the context of its intended uses, especially if 
appropriate management measures are put in place in order to mitigate possible exposure of non-
target (NT) Lepidoptera”. The EFSA GMO Panel recommended that, especially in areas of abundance 
of non-target Lepidoptera populations, the adoption of the cultivation of maize MON  810 be 
accompanied by management measures in order to mitigate the possible exposure of these species to 
maize MON  810 pollen. In addition, the EFSA GMO Panel advised that resistance management 
strategies continue to be employed and that the evolution of resistance in lepidopteran target pests 
continue to be monitored in order to detect potential changes in resistance levels in pest populations. 
The EFSA GMO Panel agreed with the overall approach and methodology proposed by the applicant 
for general surveillance, but advised the applicant to describe in more detail how information will be 
collected that could be used to assess if the intended uses of maize MON 810 are having unanticipated 
adverse environmental effects. 
From 2005 onwards, the applicant submitted to the European Commission PMEM reports on the 
cultivation of maize MON 810 according to the provisions of Directive 2001/18/EC (EC, 2001). 
From 2010 onwards, the EFSA GMO Panel received the requests from the European Commission to 
assess the annual PMEM reports submitted by Monsanto on the cultivation of maize MON 810. The 
EFSA GMO Panel therefore adopted a scientific opinion on the 2009, 2010 and 2011 PMEM reports 
(EFSA GMO Panel, 2011b, 2012a, 2013a). From the data submitted by the applicant in its previous 
reports, the EFSA GMO Panel did not identify adverse effects on the environment, human and animal 
health due to maize MON 810 cultivation. However, the EFSA GMO Panel noted shortcomings in the 
methodology and hence made recommendations for improvement of the PMEM of maize MON 810.  
On 4 March 2014, the EFSA GMO Panel received from the European Commission a request to assess 
the PMEM report submitted by Monsanto on the cultivation of maize MON 810 in 2012 taking into 
consideration comments from Member States on the report. 
TERMS OF REFERENCE AS PROVIDED BY THE EUROPEAN COMMISSION AND EFSA 
On 4 March 2014, the EFSA GMO Panel was asked by the European Commission “to evaluate the 
findings of the monitoring activities, taking into consideration the comments received from Member 
States and to assess the appropriateness of the methodology if this is found to differ compared to the 
previous season.” Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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ASSESSMENT 
1.  Introduction 
Following the terms of reference of the mandate from the European Commission, the EFSA GMO 
Panel considered whether the methodology used by the applicant to monitor maize MON 810 over the 
2012 growing season differs from the methodology applied by the applicant in its PMEM reports for 
the 2009, 2010 and 2011 growing seasons of maize MON 810 (EFSA GMO Panel, 2011b, 2012a, 
2013a). 
In addition, the EFSA GMO Panel assessed the novel datasets specific to the 2012 growing season 
(e.g. Spanish datasets from monitoring the baseline susceptibility of target pests, questionnaires 
answered by selected farmers in the European Union countries where maize MON 810 was cultivated 
in 2012, outcomes of the search for peer-reviewed publications on the safety of maize MON 810 and 
the Cry1Ab protein). 
The EFSA GMO Panel also considered the comments from Member States on the PMEM report on 
the 2012 growing season of maize MON 810 (hereafter referred to as ‘2012 PMEM report’). 
2.  Overview of information provided by the applicant 
The 2012 PMEM report shows the same structure as the previous reports and contains the following 
information: 
-  an insect resistance management (IRM) plan
4 consisting of (1) the ‘high dose-refuge’ strategy, 
including studies on farmers’ compliance with non-Bt refugia; (2) the monitoring for changes 
in baseline susceptibility of target pests; (3) a communication plan with farmers; (4) a 
remedial action plan in the event of any confirmed evolution of pest resistance; 
-  the survey
5 based on 249 questionnaires received from farmers in five European countries (i.e. 
22 in the Czech Republic, 175 in Spain, 41 in Portugal, 10 in Romania and 1 in Slovakia); 
-  a list
6 of peer-reviewed publications pertaining to the safety of maize MON 810 and/or the 
Cry1Ab protein published between June 2012 and beginning of June 2013; 
-  company stewardship activities; and 
-  alerts on environmental issues by the authorities and existing networks. 
The 2012 PMEM report is published online: 
http://ec.europa.eu/food/plant/gmo/reports_studies/report_2012_mon_810_en.htm 
3.  Assessment 
In its 2012 PMEM report, the applicant clearly states that the previously established methodologies 
were followed notwithstanding the EFSA GMO Panel recommendations to improve the methodology 
for PMEM of maize MON 810. 
The EFSA GMO Panel acknowledges that there was not enough time for the applicant to implement 
the latest EFSA recommendations (EFSA GMO Panel, 2013a). However, the EFSA GMO Panel also 
points out that its previous recommendations for improvement of the PMEM methodology of maize 
MON 810, as in its opinions on 2009 and 2010 PMEM reports, have yet to be implemented (EFSA 
GMO Panel, 2011b, 2012a). Therefore, having already highlighted the poor sensitivity of the 
methodology followed by the applicant, the EFSA GMO Panel reiterates all its recommendations 
                                                      
4  MON 810 2012 PMEM report, Appendix 6. 
5  MON 810 2012 PMEM report, Appendix 1. 
6  MON 810 2012 PMEM report, Appendices 5.1 and 5.2. Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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(EFSA GMO Panel, 2011b, 2012a, 2013a) for consideration by the applicant in the PMEM plan and 
forthcoming PMEM reports. 
Consequently, considering the unchanged methodology for PMEM of maize MON 810 in 2012, the 
EFSA GMO Panel focused its assessment on the novel datasets specific to the 2012 growing season of 
maize MON 810, i.e. 
(1)  data from the specific survey by Antama (the Spanish Foundation supporting the use of new 
technologies in agriculture) and the inspection campaign on non-Bt refugia compliance by 
Spanish and Portuguese farmers, respectively; 
(2)  Spanish data
7 from monitoring changes in baseline susceptibility of target pests (i.e. European 
Corn Borer (ECB; Ostrinia nubilalis Hübner) and Mediterranean Corn Borer (MCB; Sesamia 
nonagrioides Lefebvre)) in 2012; 
(3)  farmer responses to questionnaires in the five EU countries where maize MON  810 was 
cultivated in 2012; 
(4)  the list of peer-reviewed publications pertaining to the safety of maize MON 810 and the 
Cry1Ab protein for human and animal health and the environment. 
3.1.  Implementation of non-Bt refugia 
The EFSA GMO Panel analysed the results of the survey by Antama addressing the implementation of 
non-Bt refugia by 110 Spanish farmers (i.e. in the Ebro Valley) who cultivated maize MON 810 in 
2012. It concluded that 7 % of the farmers growing maize MON 810 in 2012 did not plant a refuge 
area. The reasons given by the farmers for not planting a refuge area were: “(1) they considered their 
farms to be small farms; (2) sowing is easier (with Bt-maize); (3) corn borers cause significant 
losses.” 
In 2012, the Portuguese inspection services visited the farmers cultivating maize MON 810 for control 
of good implementation of Portuguese law pertaining to cultivation of GM varieties. They concluded 
that there was full compliance with refuge implementation. 
As in 2011, the 2012 PMEM report still shows partial non-compliance with the implementation of 
non-Bt refugia in Spain, which was confirmed by the farmer questionnaires.
8 The EFSA GMO Panel 
therefore recommends that the applicant should maintain its efforts to increase the level of 
compliance, especially in regions of high maize MON 810 uptake. 
3.2.  Monitoring for changes in baseline susceptibility of target pests 
In line with its previous recommendation to focus the sampling of target pests in areas of high maize 
MON 810 uptake (EFSA GMO Panel, 2013a), the EFSA GMO Panel assessed the datasets
9 for the 
monitoring of changes in baseline susceptibility of the target pests in Spain. In addition to the 
aforementioned comments from Member States, a report
10 of the French Haut Conseil des 
Biotechnologies (HCB) was considered which carried out a specific analysis on the susceptibility of 
target pests over time. 
In its 2012 PMEM report, the applicant acknowledged that “the variation in Cry1Ab susceptibility 
(MIC50 and MIC90) of ECB collected in the field during the campaign 2012-2013 (…) reflected 
natural variation in Bt susceptibility among ECB origins.” Overall, Monsanto concluded that the 2012 
data analysis did not indicate a decrease of the target pest susceptibility to Cry1Ab protein.  
                                                      
7  MON 810 2012 PMEM report, Appendices 7 and 8. 
8  MON 810 2012 PMEM report, Appendix 1. 
9  MON 810 2012 PMEM report, Appendices 7 and 8. 
10 Available online: 
http://www.hautconseildesbiotechnologies.fr/IMG/pdf/131108_Surveillance_mais_MON810_2012_Commentaires_CS_H
CB.pdf Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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However, the specific analysis carried out by the HCB suggested a hypothesised increased tolerance of 
target pests in Spain when compared with the reference laboratory strain. This could be explained by, 
for example: (1) any type of change in the insecticidal Cry1Ab protein attributed to target pests (e.g. 
more or less toxic); (2) a modification (e.g. weakening) of the reference laboratory strain; and (3) an 
increased tolerance of the Spanish target pest populations to the Cry1Ab protein. The EFSA GMO 
Panel considered these three points.  
Firstly, the EFSA GMO Panel noted that a new Cry1Ab toxin batch was used from 2012 onwards. In 
its PMEM report for the 2011 growing season of maize MON 810, Monsanto reported the outcomes of 
a bridging study
11 indicating that the old toxin batch, used until 2010, and the toxin batch, used from 
2012 onwards, have similar biological activity on ECB.  
Secondly, even though the 2012 dataset shows a trend towards increased MIC
12 values, it did not show 
any significant and consistent decrease in susceptibility of the ECB and MCB field populations in 
Spain. 
The EFSA GMO Panel is of the opinion that the hypothesised increased tolerance of the Spanish target 
pest populations to the Cry1Ab toxin when compared with the reference laboratory strain, as 
suggested by the HCB, might instead be due to declining performance of the reference laboratory 
strain (e.g. infection with pathogens, inbreeding). In its 2012 PMEM report, the applicant also 
acknowledged that the reference laboratory strain might have shown poor performance but did not 
discuss the possible reasons for this. Such a statement should have been further elaborated by the 
applicant in its 2012 PMEM report. The EFSA GMO Panel therefore recommends that the applicant 
investigates the stability and quality of the reference laboratory strain.  
In order to ensure an early detection of change in susceptibility of the ECB and MCB field 
populations, the EFSA GMO Panel strongly reiterates its previous recommendation for annual 
sampling of both target pests in areas of high maize MON 810 adoption rate, especially in north-east 
Spain in 2014 (see Table 1). 
3.3.  Further considerations on the harmonised IRM plan 
As part of the harmonised IRM plan
13, the applicant proposed to sample multivoltine target pest 
populations every two years in areas where maize MON 810 adoption rate varies between 20 % and 
80 % of the total maize cultivated area. Annual sampling is foreseen only in exceptional circumstances 
in areas of high uptake (i.e. >  80  % and therefore in areas where non-Bt refugia have not been 
implemented). 
Based on the outcomes of the additional simulations with the Alstad and Andow (1995) model (see 
Appendix A of EFSA GMO Panel, 2013a), and considering that resistance evolution should focus on 
areas of high Bt maize adoption rates, the EFSA GMO Panel reiterates its previous recommendation 
that annual sampling of multivoltine target pests for maize MON 810 uptake between 50 % and 80 % 
of the total maize cultivated areas is put in place (see Table 1). 
                                                      
11 MON 810 2011 PMEM report, Appendix 8. 
12 Molting Inhibition Concentration (MIC). 
13 MON 810 2012 PMEM report, Appendix 6. Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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Table 1:   Recommended sampling frequency of target pests 
Maize MON 810 uptake
14 
in a zone 
(% total maize cultivated area) 
Sampling frequency 
For a monovoltine target 
pest population 
For a bi-/multi-voltine target 
pest population 
< 20 %  None  None 
20 % to < 50 % 
(R allele frequency of 3  %) 
Biennial Biennial 
50–80 % (R allele frequency of 1 %)  Biennial  Annual 
> 80 %
15 Annual 
3.4.  Farmer questionnaires 
The EFSA GMO Panel, in close collaboration with the EFSA Unit for Assessment and 
Methodological Support (EFSA AMU Unit), assessed the methodology followed by the applicant to 
analyse the farmer questionnaires; and identified similar weaknesses as in previous PMEM reports. 
Alongside the methodological guidance for a systematic evaluation of the farmer questionnaires, the 
evaluation of the overall 2012 farmer’s survey (including, for example, sampling of farmers, types of 
questions, method of conduct interviews, data validation, method used for the design of the statistical 
analysis) is given in Appendix A. 
Recommendations to the applicant for the improvement of the methodology are listed in Appendix A. 
However, from the analysis of the 2012 farmer questionnaires on maize MON 810, the EFSA GMO 
Panel concludes that no unanticipated adverse effects can be identified. 
3.5.  Literature review 
The applicant identified 37 publications related to maize MON 810 and/or Cry1Ab protein (published 
between June 2012 and beginning June 2013). In addition, the EFSA GMO Panel identified a further 
five papers (Albajes et al., 2012; Daudu et al., 2012; Kamota et al., 2012; Raybould et al., 2012; 
Takacs et al., 2012). 
Of all these publications, the EFSA GMO Panel identified only two publications (Albajes et al., 2012; 
Gu et al., 2013) that provide new information and were not assessed previously (for earlier 
assessment
16, see, for example, EFSA GMO Panel, 2012b, c, f, 2013a). 
–  Gu et al. (2013) reported a 97-day study on salmon (Salmo salar L.) with the initial body 
weight of 94 g with four different diets fed to triplicate pens, each with 100 salmon. Two basal 
diets were used: one free of soybean meal, and the other containing 15 % soybean meal. Each 
basal diet contained either 20 % maize MON 810 or its conventional counterpart. The diets 
were isonitrogenous and near iso-energetic. Zootechnical parameters were not influenced by 
the different diets. However, the whole body lipid content was significantly reduced in both 
MON 810 groups. The apparent protein and mineral digestibility (both lower in the soybean-
containing diets) was decreased by MON 810 in both basal diets. No significant difference due 
to MON 810 in haematology and clinical chemistry was found. The relative weight of the 
whole intestine and the proximal intestine was significantly increased by MON 810 compared 
with its conventional counterpart after 33 days of feeding. However, the significance of this 
finding disappearing by the end of the study. Leucine aminopeptidase, used as a marker of 
enterocyte maturity, was reduced in the proximal intestine in both MON  810 groups, 
                                                      
14 At the time of adoption of this opinion, maize MON 810 was the only Cry1-expressing maize cultivated in the EU. 
However, the EFSA GMO Panel recommends that in future the applicant takes into consideration the overall uptake of 
Cry1-expressing maize when identifying zones of high adoption for sampling target pests. 
15 In some regions where farmers do not comply with non-Bt refugia implementation. 
16  See also http://registerofquestions.efsa.europa.eu/roqFrontend/questionsListLoader?unit=GMO (with Question Number 
EFSA-Q-2014-00192). Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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compared with its conventional counterpart. Gamma-interferon (detected using real time 
quantitative polymerase chain reaction (qPCR)) in the distal intestine was significantly higher 
for MON 810 in the soybean-free basal diet. In conclusion, 20 % dietary MON 810 appears to 
have the potential to introduce immunogenic reactions in salmon of unknown consequences. It 
should be noted that the reported changes are the result of only about 2 % dietary protein. 
However, owing to the absence of non-GM commercial varieties, there is no measure of 
natural variation in the parameters measured. Consequently, it is not possible to conclude on 
the relevance of these findings in practice. 
–  Albajes et al. (2012) reported results from a Spanish study monitoring possible effects of 
maize MON 810 varieties on non-target organisms (i.e. predators as natural enemies). During 
the two-year study, the authors monitored the abundance of certain predators found in maize 
MON 810 fields compared with non-GM maize fields. The study did not show significant 
differences in predator densities except for rove beetles (i.e. Staphylinidae). A significantly 
higher number of rove beetles was found in one out of the two non-GM fields monitored. 
Compared with other non-target predators studied by Albajes et al. (2012), the overall number 
of rove beetles was very low. The authors also highlighted the fact that the effects on rove 
beetles are generally difficult to interpret because this family is heterogeneous in feeding 
habitats. Similar results had already been reported by de la Poza et al. (2005) and Balog et al. 
(2010). However, Garcia et al. (2010) indicated that the same rove beetle as monitored by 
Albajes et al. (2012) is not susceptible to Bt toxin. The authors also discussed the power of the 
statistical analysis of the field trials. Therefore, pending clear explanations for the 
aforementioned difference observed in rove beetles abundance, the authors concluded that 
further monitoring needs to be considered (e.g. susceptibility of rove beetles to Bt toxin, 
spatial and temporal exposure to maize MON 810/Cry1Ab toxin).  
Consequently, in the light of the outcome of the two-year study by Albajes et al. (2012), the EFSA 
GMO Panel recommends that the applicant follows up possible adverse effects of maize MON 810 on 
rove beetles (e.g. through literature review). 
4.  Conclusions and recommendations 
In its 2012 PMEM report, the applicant clearly states that the previously established methodologies 
were followed notwithstanding the EFSA GMO Panel recommendations to improve the methodology 
for PMEM of maize MON 810. The EFSA GMO Panel acknowledges that there was not enough time 
for the applicant to implement the latest EFSA recommendations (EFSA GMO Panel, 2013a). 
However, the EFSA GMO Panel also points out that its previous recommendations, as in its opinions 
on the 2009 and 2010 PMEM reports, have yet to be implemented (EFSA GMO Panel, 2011b, 2012a). 
Therefore, having already highlighted the poor sensitivity of the methodology
17 followed by the 
applicant, the EFSA GMO Panel reiterates all its recommendations (EFSA GMO Panel, 2011b, 2012a, 
2013a) for consideration by the applicant in the PMEM plan and forthcoming PMEM reports. 
Concerning the monitoring for changes in baseline susceptibility of target pests, the EFSA GMO Panel 
is of the opinion that the hypothesised increased tolerance of the Spanish target pest populations to the 
Cry1Ab toxin when compared with the reference laboratory strain, as suggested by the HCB, might 
instead be due to declining performance of the reference laboratory strain. The EFSA GMO Panel 
therefore recommends that the applicant investigates the stability and quality of the reference 
laboratory strain. 
The EFSA GMO Panel concludes that the 2012 PMEM report did not show any significant and 
consistent decrease in susceptibility of the target pests field populations in Spain. However, in order to 
ensure an early detection of change in susceptibility of the ECB and MCB field populations, the EFSA 
GMO Panel strongly reiterates its previous recommendation for annual sampling of both target pests 
                                                      
17 For further details, see also http://registerofquestions.efsa.europa.eu/roqFrontend/questionLoader?question=EFSA-Q-2012-
00597 Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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in areas of high maize MON 810 adoption rate, especially in north-east Spain in 2014 (EFSA GMO 
Panel, 2013a). 
The EFSA GMO Panel further assessed two publications (Albajes et al., 2012; Gu et al., 2013) that 
provided new information and were not assessed previously. Consequently, the EFSA GMO Panel 
advises the applicant to follow up possible adverse effects of maize MON 810 on rove beetles (e.g. 
through literature review). In the publication by Gu et al. (2013), the authors reported local 
inflammatory responses in salmon fed maize MON 810. Currently it is not possible to conclude on the 
relevance of these findings in practice. 
OVERALL CONCLUSIONS AND RECOMMENDATIONS 
The data submitted by the applicant in its 2012 PMEM report do not indicate any adverse effects on 
human and animal health or the environment arising from maize MON  810 cultivation in 2012. 
However, the sensitivity of the methodology is still considered too low for an early detection of 
possible adverse effects. Therefore, the EFSA GMO Panel strongly reiterates all its previous 
recommendations for the improvement of the PMEM methodology of maize MON 810 (EFSA GMO 
Panel, 2011b, 2012a, 2013a). 
In addition, the EFSA GMO Panel recommends that the applicant: (1) further investigates effects 
observed during the monitoring of baseline susceptibility of target pests in Spain; (2) follow-up 
possible adverse effects of maize MON 810 on rove beetles. 
DOCUMENTATION PROVIDED TO EFSA 
1.  Letter from the European Commission, dated 4 March 2014, to the EFSA Executive Director 
requesting the assessment of the MON  810 monitoring report for the 2012 cultivation season 
provided by Monsanto; the 2012 PMEM report was annexed to the letter. 
2.  Comments from Member States on the PMEM report for cultivation of maize MON 810 in 2012. 
3.  Acknowledgement letter, dated 21 March 2014, from the EFSA Executive Director to the 
European Commission. 
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APPENDIX 
Appendix A.  AMU technical report on the evaluation of farmer questionnaires  
BACKGROUND 
This Appendix A was prepared by the EFSA AMU Unit to support the EFSA GMO Panel in its 
evaluation of the PMEM report on maize MON 810 for the 2012 growing season, specifically to 
provide methodological guidance on evaluation of the farmer questionnaires submitted as part of the 
general surveillance (GS) programme, which aimed to identify adverse affects of the GM maize or its 
use on human and animal health or the environment that had not been anticipated in the ERA. 
METHOD 
Evaluation criteria were developed based on the principles of design for cross-sectional studies, and in 
particular surveys. The evaluation grid can be applied to surveys used for GS of GM plants. In July 
2011, the EFSA GMO Panel updated its guidance on the PMEM of GM plants (EFSA GMO Panel, 
2011a). The criteria reflect the recommendations in this guidance document. These criteria were 
previously applied in the assessment of the 2009 - 2011 MON 810 PMEM reports and the 2010 – 2011 
Amflora PMEM reports (EFSA GMO Panel, 2011b, 2012 a,d,e). 
Study design principle  Criteria 
Sampling frame  1)  The sampling frame used is specified 
2)  The total population included in the sampling frame is 
specified 
3)  The characteristics of the population included in the 
sampling frame are described, including region, 
agricultural practices, GM cultivation 
4)  The sampling frame coverage is appropriate for GM 
cultivation in the EU 
Sampling method (sample 
bias) 
1)  The sampling method to select sample units from the 
sampling frame is described 
2)  The sampling method ensures sampling units from 
representative environments, reflecting the range and 
distribution of plant production systems and 
environments exposed to the GM plants and its 
cultivation are sampled 
3)  A list of sample units selected from the sample frame is 
provided 
4)  The sampling method minimises selection bias 
Sample size (sample 
precision) 
1)  The size of the adverse effect to be measured is 
specified and scientifically justified and is within an 
acceptable limit of change. 
2)  The significance level is specified and the chosen level 
is scientifically justified (Type I error rate) 
3)  The power is specified and the chosen level is 
scientifically justified (Type II error rate) 
4)  A literature reference for the sample size method is 
provided 
5)  The sample size calculation method is appropriate for a 
proportion in a cross-sectional study 
6)  The sample size is sufficient to detect an adverse effect 
related to GM cultivation 
 
Survey response rate (non 
response bias) 
1)  Follow-up method for non-responders is described and 
appropriate 
2)  Response rate is specified Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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3)  Details of losses in sampling are described 
4)  The number of partial responses and reasons for non-
completion are specified 
5)  Comparison is made between characteristics of 
responder group and non-responder group 
6)  Comparison is made between characteristics of 
responder group  and independent sources of 
information about the target population 
7)  The effects of non response bias have been minimised 
 
Instrument design  1)  The study design includes considerations to avoid 
interviewer bias 
2)  Where interviewers are used the interviewer training is 
described 
3)  The selection of open and closed questions is 
appropriate for the question type 
4)  The questions are clearly phrased and not open to 
misinterpretation 
5)  The questions encourage independent and objective 
responses 
6)  The comparator used in the study is described and 
appropriate for general surveillance 
7)  The instrument has been previously tested and 
validated 
Instrument validity  1)  Content validity – the survey includes questions 
relevant to assess 
•  Background data 
Identifier of location of monitoring site and comparator site, 
surrounding landscape, type of field margins, proximity to 
conservation areas, cultivation and management of the GM field 
including recent history and previous cropping, soil (type, 
structure, quality), nutrient status, fertilization, irrigation. 
•  Data informing on possible change in behaviour and 
performance of GMP 
Other GMPs cultivated, number of years of cultivation of GMP, 
cultivation and tillage from the removal of the previous crop to 
seed sowing, crop husbandry including sowing/planting date, 
post planting management, crop emergence, growth (vigour, 
height), pest, disease and weed management, flowering, 
standing ability, harvesting date and methods, yield, post-
harvest management and subsequent cropping of the site, post-
harvest storage, handling, processing, feeding 
•  Data informing on possible ecological/environmental 
impacts of GMP on the protection goals and 
measurement 
Weed and pest populations, observations of other flora and 
fauna such as insects, birds and mammals, pollination and 
presence of pollinators, health of humans and performance of 
livestock. 
•  Implementation of specific management requirements 
Implementation of risk management measures, coexistence 
segregation measures, stewardship recommendations, specific 
management due to regional environmental requirements 
2)  Criterion validity – agronomy parameters reported in 
the survey are compared with field trial data to test for 
concurrency 
3)  External consistency - results from survey are 
compared to and conform with independent external 
data sources (for example pest/weed occurrence 
reports, soil characteristics from geological surveys, Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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authorisations and use reports for plant protection 
products) 
4)  Plausibility of responses – results for cultivation 
methods, agronomy parameters and weed/pest 
management practices reported in the survey conform 
to European agricultural practices 
5)  Construct validity – consistency and agreement 
between outcome variables is examined 
Data validation  1)  Data validation procedure are documented 
2)  Results excluded from the statistical analysis during 
validation are reported 
3)  Missing values are reported 
 
Longitudinal aspects  Comparison with survey results from previous years 
1)  The survey is applied to the sample unit for multiple 
years in order to assess residual effects 
 
Statistical analysis  1)  Objective and hypotheses for analysis are clearly stated 
2)  A statistical analysis plan is provided 
3)  Statistical analysis includes analysis of pre-defined 
sub-groups according to PMEM guidance e.g country 
4)  Statistical analysis is appropriate for the data types 
5)  Results are clearly and consistently presented 
6)  The report should include descriptive statistics for the 
outcome variables 
7)  The issue of multiplicity is addressed 
8)  Methods for handling missing values are described 
9)  Where appropriate confidence intervals should be 
provided 
10) The results of post-hoc analysis should be identifiable 
Report conclusions  1)  The report conclusions are clearly stated 
2)  The study design is appropriate to assess the 
conclusions 
3)  The data presented supports the conclusions presented 
in the report 
RESULTS 
Sampling frame 
1)  Sampling frame specification 
Appendix 1 of the 2012 MON 810 report specifies that, in Portugal and Romania, the sampling frame 
for the survey was a public register. In Czech Republic and Slovakia, customer lists obtained from 
companies selling seeds were used. In Spain, the country with highest cultivation of maize MON 810 
and therefore the largest number of surveyed farmers, no suitable sampling frame was available. As a 
consequence surveyors used previous contacts (the report states that ‘the interviewers identify MON 
810 cultivating farmers by knowledge from previous surveys or search in the region’). 
2)  Population included the sampling frame 
Appendix 1 of the 2012 MON 810 report did not include information on the number of farmers in the 
sampling frame. The report states that ‘the total number of farmers cultivating MON 810 per country 
is not known’. However, it is indicated that ‘In the moment, only the total cultivated area (in ha) is 
known instead of the total number of growers (and of fields and field sizes). That implies that the 
sampling frame for this survey can not be based on the whole of fields with MON 810 cultivation in 
Europe. Therefore a quota considering the area of cultivation (ratio of country and total area) will be 
the first subdivision factor. Additionally, the product situation (and therefore the field sizes) within the 
countries serves for the second subdivision factor. Both subdivision factors result in the number of 
farmers to be monitored per year and country.’ Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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3)  Characteristics of the population included in the sampling frame 
Appendix 1 of the 2012 MON 810 report did not include information on the characteristics of the 
farmers included in the sampling frame. Information on the number of farmers in the sampling frame 
according to country, region, agricultural practices, size of farm/number of fields and previous 
cultivation of GM crops is important. 
4)  Sampling frame coverage 
Information on the sampling frame was not provided in Appendix 1 of the 2012 MON 810 report, and 
therefore this is difficult to assess. The report states that ‘The customer lists of the seed selling 
companies do not completely cover all MON 810 cultivating farmers, so that some are missing’ but 
does not try to characterise the missing farmers. Table 3.2 indicates that farmers from all the countries 
growing maize MON 810 were included in the survey. The percentage of maize MON 810-planted 
surfaces surveyed ranged between 3.3 % in Spain to 99.5 % in Romania. For Europe as a whole, 7.1 % 
of maize MON 810-planted surfaces were surveyed – this is a decrease from 12.5 % in 2009, 13.3 % 
in 2010 and 9.9 % in 2011. In fact, in 2012 a decrease in the number of hectars (ha) of monitored 
planted MON 810 surfaces was observed in comparison to 2011 (9118 in 2012 vs. 11330 in 2011). 
Since the survey size per year is fixed at 250 farmers and the area of maize MON 810 cultivation has 
increased this proportion may continue to decrease. Full details on the source of the sampling frame, 
the number of farmers and the major characteristics of the farmers should be included in the survey 
report. The national registers set by Member States on the cultivation of GM crops would be the 
optimum sampling frame, however the PMEM report notes that, when using public registers, they ´do 
not necessarily contain the contact data of the farms so it is often very difficult to identify them.´ Both 
in cases of incomplete customer lists of the seed selling companies and of incomplete contact data in 
public registers, it needs to be considered whether the data might be missing systematically. 
Sampling method 
1)  Selection of sample units 
Appendix 1 of the 2012 MON 810 report states public registers and customer lists of the seed selling 
companies have been used as sampling frames in 2012, but in one country no sampling frame was 
available. For this country, the report states that ‘the interviewers identify MON 810 cultivating 
farmers by knowledge from previous surveys or search in the region.’ Survey design methodology 
requires the sampling frame to be representative for the target population, in this case European 
farmers growing MON 810, and that the random selection process is applied to the sample units in the 
sampling frame prior to proceeding with the interviews. A description of the method to ensure that 
units are randomly selected from the sampling frame should be included in the report, including where 
relevant the statistical software and/or the program code used for this procedure. 
2)  Sampling of units from representative environments 
Appendix 1 of the 2012 MON 810 report states ‘Sampling of these 2500 fields should ensure to reflect 
the range and distribution of plant production systems and environments exposed to the GM plant and 
its cultivation. This range, on the one hand, is characterised by the growing season (year and its 
climatic, environmental conditions). On the other hand, it is characterised by the regions where GM 
cultivation takes place. Regions may be various production systems, regulatory requirements, agro-
political and socio-economic conditions and can therefore be best described by European countries. 
Sampling therefore takes place within strata (defined by years and countries of cultivation)’. It is also 
further stated that: ‘Subdividing the number per year into the cultivation regions considers fluctuant 
adoption of the GM plant (grade of market maturity) and therefore is performed yearly for the actual 
situation’ and that: ‘Consequently, cultivation areas with a high uptake of the GM plant will be over-
represented by a high number of fields to be monitored. Within each stratum (per year and country) 
the determined number of monitoring units is selected randomly where each field has the same chance Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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to be surveyed. The whole sampling procedure ensures that the monitoring area will be proportional 
to and representative of the total regional area under GM cultivation.’ 
This differs from the 2011 MON 810 report, which stated: ´two strategies for selecting farmers are 
applied: in MS with a high rate of market penetration a certain number of farms will be selected 
whereas in MS with low cultivation rates preferably all MON 810 cultivating farmers are interviewed´ 
and from the 2010 MON 810 report which stated: ´For selecting farmers in countries with higher 
market penetration a procedure is applied to select: at least 10 % of farmers and 10 % GM area per 
region and at least 20 % of new farmers each year´. To ensure units are selected from representative 
environments (regions with high uptake of maize MON 810), a proportion of farmers to be selected 
from each strata (e.g. country) should be clearly defined and consistently applied in each year of the 
survey. It is described that the number of farmers to be monitored per year and country is determined 
based on two subdivision factors (mentioned above) but it is not entirely clear how this is done. For 
example, based on table 3.2, Spain seems to have 90.1 % of the total European planted MON 810 
surfaces but contributing only about 70.3 % of the questionnaires for 2012. Moreover, the claim that 
each field within a stratum has the same chance to be surveyed is not entirely substantiated, since 
sampling selection considers farmers and not fields and also it is stated that: ‘In the moment, only the 
total cultivated area (in ha) is known instead of the total number of growers (and of fields and field 
sizes). That implies that the sampling frame for this survey can not be based on the whole of fields with 
MON 810 cultivation in Europe.’  
3)  Proportion of sample units selected 
The number of farmers surveyed in each country is provided, but no indication of the total number of 
farmers in each country and region included in the sampling frame is given. Table 3.2 describes the 
proportion of maize MON 810-planted area covered in the survey. Information on the farmers 
included in the sampling frame and selected from the sampling frame should be provided as evidence 
that the sampling method has been successfully implemented. 
4)  Selection bias 
If the number of farmers cultivating maize MON 810 increases, it will be difficult to ensure all farmers 
within a region are interviewed and, as a consequence, an appropriate sampling methodology becomes 
more important. The report provides limited information on the sampling methodology and the 
possibility of selection bias and achievement of inadequate power in the survey cannot be excluded. 
The grouping of sample units according to the strata and random selection of sample units from within 
the strata should be performed using the specified sampling frame prior to conducting the interviews. 
A description of the method to ensure that units are randomly selected from the sampling frame should 
be included in the report, including where relevant the statistical software and/or the program code 
used for this procedure. The proportion of new farmers and farmers with previous experience of maize 
MON 810 selected from the sampling frame for each region should be presented in the report to 
provide evidence that the sampling method ensures that areas of intensive maize MON 810 cultivation 
are appropriately covered in the survey. If the used sampling frames (public registers and customer 
lists obtained from companies selling seeds) were missing information in a systematic way (i.e. 
specific subsections of the farmers’ populations) then bias could be introduced in the study if the 
reasons for the missing information would be related to the study outcomes. Moreover, in the case of 
Spain, where no suitable sampling frame was available, it was noted that: ‘Here, the interviewers 
identify MON 810 cultivating farmers by knowledge from previous surveys or search in the region.’ 
This approach cannot guarantee a representative sample, and therefore, it has a possibility of 
introducing bias (the direction of which cannot be predicted). It is not explained how exactly this 
selection is done, however, it is possible that it might make it more likely to sample some of the same 
farmers in consecutive years, perpetuating a possible bias, in case some bias existed in the first place.     
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Sample size 
1)  Size of the adverse effect 
Appendix 1 of the 2012 MON 810 report states that the null hypothesis is that the proportion of 
responses that are not ´as usual´ is equal to or above 10 %. Therefore, the threshold or margin for 
adverse effects is 10 % (i.e. 5 % above the baseline). No specific reference from the scientific 
literature was provided to support the selection of 10 %; however, for this type of study 10 % 
represents an acceptable limit of change. A 10 % effect size has also been selected in a framework 
proposal for post-release monitoring of second-generation crops with novel traits in Canada (Beckie et 
al., 2010). 
2)  Type I error rate 
The type I error rate is α = 0.01 in Appendix 1 of the 2012 MON 810 report. This denotes that there is 
a 1 % probability of rejecting the null hypothesis that there is a ‘proportion of adverse effects equal to 
or greater than 10 %’ when it is true, i.e. failure to detect a true adverse effect. A type I error rate of 1 
% is conservative and acceptable. It needs to be noted that the error rates are specified for each one-
sided test, separately, but it is not clear what these error probabilities would be if both tests (for each 
question) were considered together. 
3)  Type II error rate 
The type II error rate is β = 0.01 in Appendix 1. This denotes that there is a 1 % probability of not 
rejecting the null hypothesis that there is a ‘proportion of adverse effects equal to or greater than 10 %’ 
when it is false, i.e. falsely detecting an adverse effect. The selection of 0.01 will result in a large 
sample size. However, it needs to be noted that this error rate will be realised only with the overall 
calculated sample size of 2500. For a yearly survey, as calculated in section 2.6, for a real proportion 
of 5 % of a plus or minus answer, a sample size of 250 and an α of 0.01 the power to detect ‘no effect’ 
would be 73 %, i.e. the type II error rate, β, would be 0.27.   
4)  Reference for the sample size method 
The sample size calculation was performed using the methodology described in Rasch et al. (2007). 
5)  Sample size calculation 
The sample size is calculated assuming difference testing. 
 
6)  Sample size 
As concluded for the 2011 PMEM report, the selection of parameters for the sample size calculation is 
conservative. In 2012, 249 farmers were sampled – this is one farmer less than the planned 250 
farmers per year. Nonetheless, it is likely that the same farmer may be surveyed in different years and 
therefore sample units may not be independent from each other. Consideration of this factor should be 
included in the sample size calculation. Most importantly, the power of the study will be achieved only 
when the sample size of 2500 farmers/fields surveyed is achieved after 10 years. Concerning the 
‘allocation’ of the calculated sample size among the participating countries, it is described that the 
number of farmers to be monitored per year and country is determined based on two subdivision 
factors (mentioned above) but it is not entirely clear how this is done.   
Survey response rate 
1)  Follow-up for non-responders Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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Appendix 1 of the 2012 MON 810 report states ´The surveys are performed after the planting season, 
the farmers are provided with a copy of the questionnaire at least two weeks before a telephone 
interview or interviewed face-to-face.´ This should reduce the number of non-responders in 
comparison with other survey methods. No information is provided in the report on the follow-up for 
non-responders.  
2)  Response rate 
The response rate is provided (95.7 % for Czech Republic and 100 % for Spain, Portugal, Slovakia 
and Romania). In Appendix 1 of the 2012 MON 810 report, the fact that one farmer from the Czech 
Republic refused to participate is recorded. 
3)  Losses in sampling 
No details of losses in sampling are included in the report. The number of farmers selected from the 
sampling frame but not contacted by the interviewers should be stated in the report. 
4)  Partial responses and reasons for non-completion 
This information was not presented in the report. However, the use of trained interviewers may have 
resulted in no cases of partial completion of the survey. 
5)  Characteristics of responder group and non-responder group 
One farmer from the Czech Republic declined to participate. It is important to know if a specific 
subgroup of farmers is not participating in the survey and therefore is not represented in the survey 
findings; consequently, this comparison should be presented in the report. 
6)  Characteristics of responder group compared with the target population 
No comparison between the responder group and the target population is provided in the report. Where 
available, national registers for the cultivation of GM crops should be compared with the 
characteristics of the farmers surveyed in terms of geographical location and farming practices to 
ensure that the farmers surveyed are representative of the target population. 
7)  Non response bias 
The losses to sampling should be fully documented in the report to provide evidence that there is no 
non-response bias. It is important to know if a specific subgroup of farmers is not participating in the 
survey and therefore is not represented in the survey findings. 
Instrument design 
1)  Interviewer bias 
The 2012 MON 810 survey used third parties to perform the interviews, with the exception of 
Romania, where Monsanto field representatives assisted the farmers to fill in the questionnaire. The 
use of third-party interviewers can prevent interviewer bias. A lot of attention should be paid to the 
standardisation of the delivery of the questions from all interviewers, since the interviews should be 
conducted in the same way for all participants. This means also that the administration of the 
questionnaire should be done in the same way for all participants; in 2012, some interviews were done 
during personal visits, while others were done by telephone communication (in which case the farmers 
were getting the questionnaire two weeks in advance).  
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2)  Interviewer training 
Appendix 1 states that ‘all interviewers have been trained to understand the background of the 
questions’, and mentions that the interviewers also draw on previous experience in administering the 
questionnaire to ensure that the questions are completed correctly. In addition, a ´user’s  manual´ is 
provided to the interviewers. 
3)  Question type 
The questionnaire contains 27 closed questions, which require a comparison between the 
representative GM maize field and the representative conventional maize field. For these questions the 
response options are “´the same´ or ´different/changed´ ” or “ ´as usual´ or ´worse´ or ´better´ ”. It is 
these questions that are primarily analysed in the report. Where the response is not ´same/as usual´, 
there is an option to provide more details as free text. There is also a mix of closed and open questions 
to gather additional information about the farming practices on the farm and five closed questions to 
gather information about good agricultural practice and implementation of non-Bt refuge(s). The 
combination of open and closed questions allows quantitative analysis of the comparisons between the 
GM maize field and the conventional maize field, and, where differences occur between the two field 
types, explanatory analysis can be performed using the information from the free text questions. 
4)  Phrasing of questions 
The questionnaire uses questions based on farm records and should be understood by a grower. 
5)  Independent and objective responses 
Overall, the questionnaire seeks to obtain an objective set of responses to summarise the results and 
experiences during the growing season for maize. Nevertheless, the questionnaire could be improved 
by adjusting the balance between crop performance questions and questions on the general farm 
environment by addressing the latter more fully. Furthermore, qualitative responses may sometimes 
relate to a subjective assessment on the part of the farmer. An effort should be made to use objective 
measurable outcomes, whenever this is possible.   
6)  Comparator 
The questionnaire relies on a comparison between a representative GM maize field and a 
representative conventional maize field in order to detect unanticipated adverse effects. Consequently, 
the choice of representative fields and the recollection of similarities and differences are crucial to the 
success of the survey. The report provides no indication about the comparator fields selected by the 
farmer for comparison in the survey, however Figure 3.3 of mean percent of maize MON 810 
cultivation area of total maize area per farmer appears to indicate that on all farms some non-GM 
maize is grown that may be suitable as a comparator. It is recommended that the questionnaire 
contains questions to record clearly whether the comparator field is growing on the same farm at the 
same growing season and the variety of the comparator. If no comparators are being grown spatially or 
temporally close to the GM crop, then the rationale for selecting another comparator (e.g. maize grown 
in previous years) should be fully described. The comparators selected by the farmers for the survey 
should be summarised in the PMEM report. 
7)  Validation of the instrument 
The questionnaire was developed by the German Federal Biological Research Centre for Agriculture 
and Forestry and maize breeders and statisticians in Germany, and the results of the pilot of this 
questionnaire were published in 2004 (Wilhelm et al., 2004). The questionnaire was used in annual 
PMEM reports in the period 2006–2012. Any future amendments to the questions should be made 
giving consideration to pooled analysis of the results over 10 years. The report mentions: ‘The format Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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of the questionnaire is reviewed on a yearly basis based on the outcome of the latest survey. As 
appropriate, adjustments are made to improve the statistical relevance of the collected data’. As a 
consequence of this approach, increased care should be taken to assure the comparability of the 
obtained data from year to year. 
Instrument validity 
1)  Content validity 
-  Background data 
Background data relating to geographical location at country and county level, surrounding 
environment, soil type, crop rotations in the previous 2 years and fertiliser treatments and irrigation are 
collected by the questionnaire. It would be of value to take longitude and latitude measurements of the 
representative GM maize field; information of this nature would facilitate linkage with other spatial 
monitoring datasets. In addition, the questionnaire should record for how many years the farmer has 
been growing maize MON 810 on the farm, and the question on crop rotation should also record, for 
rotations in which maize was grown, whether this was GM or conventional maize. 
-  Data informing on possible change in behaviour and performance of the GM crop 
The following characteristics were monitored to obtain data on any change in the behaviour and 
performance of maize MON 810: crop rotation, time of planting, tillage and planting technique, insect 
control practices, weed control practices, fungal control practices, fertiliser application, irrigation 
practice, time of harvest, germination vigour, time to emergence, time to male flowering, plant growth 
and development, incidence of stalk/root lodging, time to maturity, and yield. It is noted that 
information on plant protection products applied to the GM maize field was collected, but the same 
information was not supplied for the conventional field. In order to fully explain changes in plant 
protection product use, the products applied to the conventional field should also be recorded, and the 
quantities applied over the season to the GM maize field and the comparator field should be recorded. 
-  Data informing on possible ecological/environmental impacts of the GM crop on the 
protection goals and measurement 
The following characteristics were monitored to obtain information on possible 
ecological/environmental impacts of maize MON 810 on protection goals: occurrence of MON 810 
volunteers, disease susceptibility, insect pest control (O. nubilalis), insect pest control (Sesamia spp.), 
pest susceptibility, weed pressure, occurrence of insects, occurrence of birds, occurrence of mammals. 
For the closed questions on occurrence of insects, birds and mammals, the option ´Do not know´ is 
included; however, it has been excluded in other closed analysis questions, forcing the farmer to make 
a clear assessment. Allergenicity in people handling the GM crop during production and harvesting 
could be an adverse effect: a question to assess this should be included in the questionnaire. It is 
important that the question is phrased in such a way that it discriminates between allergenicity to the 
GM crop and background levels of hay fever type symptoms. 
-  Compliance with good agricultural practice 
Section 4 requests information on compliance with good agricultural practice, and in this case the 
planting of non-Bt refuge(s). 
2)  Criterion validity 
The scientific opinion of the EFSA GMO Panel on the renewal of the authorisation for maize MON 
810 commercialisation in the EU (EFSA, 2009) states that ´The information available in the renewal 
applications gives no reason to change the opinion that maize MON 810 is agronomically and Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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phenotypically equivalent to currently grown non-GM maize varieties, with exception of the insect 
resistance conferred by the Cry1Ab protein.´ The 2005 scientific opinion for maize MON 863 × MON 
810 × NK603 (EFSA, 2005) states ´Plants of the same field trials as for compositional analysis, 
except for a difference in glyphosate treatment (see section 3.2.2) were compared for their agronomic 
and phenotypic characteristics. These characteristics included seedling vigour, crop growth stages 
(for example, the stage at which silking and pollination occurred), height of the plant and ear 
(attachment containing the cob and kernels), root lodging (plants leaning to the surface), stalk lodging 
(plants with stalks broken below the ear), dropped ears, final stand count, stay-green and kernel yield. 
The plants tested showed no particular deviations in any of these parameters. In addition, plant 
damage due to insect feeding in two locations and due to weather in one location appeared to occur 
preferentially in plots planted with reference lines.´ Report MSL-18567 (Carringer et al., 2004) 
includes data on the agronomic parameters assessed in the above opinion. In the case of seedling 
vigour, both maize MON 810 and the reference varieties had ´excellent´ vigour, with the exception of 
one site where one reference variety was classed as poor and one as average. Stalk lodging in plants 
near harvest was observed more frequently in the reference varieties, and at one site root lodging in 
plants close to harvest was observed more frequently in the reference varieties. In the case of the other 
agronomic parameters, there was no particular deviation between maize MON 810 and the reference 
varieties. Appendix 1 of the 2012 MON 810 report assessing the characteristics of maize MON 810 
reported ´unchanged germination vigour, unchanged time to emergence, unchanged time to male 
flowering, unchanged plant growth and development, lower incidence of stalk/root lodging, delayed 
time to maturity, higher yield and unchanged occurrence of MON 810 volunteers.´ Comparing the 
field trial data with the farmer survey data provides an opportunity to check the validity of the 
farmers’ responses. It appears that there may be differences between field trial data and the 
questionnaire: there are a number of possible explanations for this, e.g. the conventional crops grown 
on the farms differ from the comparator variety used in the field trials, the information provided by the 
farmers is biased or erroneous or the GM crop is performing differently on farm-scale cultivation 
(possibly performing better when the cultivation conditions are less than optimal). It is of value to 
select parameters measured using a ´gold standard´ methodology and to contrast these with the 
responses in the survey to ensure the validity of the reported responses. 
3)  External consistency 
Comparison of the data reported in the survey with information from independent data sources 
provides a further opportunity to test the validity of the responses. The information on soil quality 
offers the opportunity to compare it with the information held in the Soil Profile Analytical Database 
for Europe (SPADE-2) (Hollis et al., 2006). Figure 1 shows the information on top soil organic carbon 
contained in this database. The MON 810 survey reports organic carbon content values between 0.6 % 
and 5.9 % with a mean of 1.8 %. It can be seen that this range falls within that of the SPADE-2 range 
for organic carbon content. It should be noted that the SPADE-2 database provides a useful dataset for 
European soil properties but that the values are based on a limited set of soil samples for each EU 
country. 
 
Figure 1:   Distribution and descriptive statistics of top soil organic carbon contents in SPADE-2 
forfree-draining non-organic soils. Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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4)  Plausibility of responses 
The report states that: ‘All data are entered and controlled for their quality and plausibility. A quality 
control check first checks the completeness of the data. Some data fields (especially the monitoring 
characters or comments in case of farmer‘s assessments differ from As usual) are defined to be 
obligatory, therefore missing values or unreadable entries are not accepted. Furthermore the values 
are checked for correctness (quantitative values within a plausible min-max range, qualitative values 
meeting only acceptable parameter values). Plausibility control checks the variable values for their 
contents, both to find incorrect answers and to prove the logical connections between different 
questions. It also looks for the consistency between Plus/Minus-answers and specifications, i.e. 
whether all these answers were provided with a specification and whether the specifications really 
substantiated the Plus/Minus-answers’. 
It is indicated that the sowing and harvest times were used to check the plausibility of the responses 
provided by the farmers: the sowing time ranged from 1 March 2012 to 7 July 2012 and the harvest 
time for maize grain ranged from 15 August 2012 to 30 December 2012 and for maize forage from 20 
August 2012 to 30 October 2012. 
5)  Construct validity 
The questionnaire is able to detect changes in characteristics of the GM maize field compared with the 
conventional field that could be predicted when the nature of the genetic event in MON 810 is 
considered. Maize MON 810 expresses the cry1Ab coding sequence, which encodes an insecticidal 
protein, Cry1Ab. The responses to the survey indicated that, for the maize MON 810 field, insecticide 
application and corn borer control practices were different: owing to a reduction in insecticides applied 
to control corn borers, the yield was higher, there was a lower incidence of root and stalk lodging and 
less susceptibility to diseases and pests. The questionnaire also indicated that the control of ECB and 
pink borer in maize MON 810 fields was very good. The report proposes that the change in previously 
mentioned characteristics is due to the increased protection from corn borer damage. This hypothesis 
is credible and indicates consistency and agreement among outcome variables. 
Data validation 
1)  Validation procedures 
Section 2.7 of Appendix 1 describes the data management and quality control procedures. It states that 
‘For not readable entries in the questionnaires, queries were formulated and the field representatives 
or farmers were asked for clarification. These entries in the database were corrected’. In section 3.1 it 
is further explained that ‘After the first quality and plausibility control, 27 farmers were contacted 
again to provide additional clarifications (10 from Romania, 6 from Spain, 6 from Portugal and 5 
from Czech Republic). Examples of items that had to be clarified were incorrect variety names (MON 
810 varieties as well as conventional varieties) and missed answers (surrounding environment, soil 
quality, weed and pest control practices in conventional maize as well as in MON 810, date of harvest, 
application of fertilizer and weed pressure in MON 810). Several farmers were also asked to clarify 
some inconsistencies between weed and pest control practices in conventional maize compared to 
MON 810, and plant protection products used in MON 810. Furthermore, discrepancies between 
named conventional varieties and planting of a refuge had to be resolved. After including the 
corrections, the quality and plausibility control confirmed that all 249 questionnaires could be 
considered for analysis’. In this report, the number of questionnaires that require further clarification 
with the farmers is included, however, a classification by error types should also be presented. 
2)  Exclusion of results 
All completed questionnaires (249) were included in the analysis. Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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3)  Missing values 
It is stated in the report: ‘When farmers gave no statement, these answers are accounted as missing 
values and therefore not considered valid’. There are several questions for which the number of valid 
answers was less than 249. In the analysis of each of the monitoring characteristics, the number of 
responses for each value was shown in the table, including the missing values where they occur. In 
general, the missing values were few. 
Longitudinal aspects 
1)  Sampling over multiple years 
The repeated sampling of a sample unit needs to be considered in the sample size calculations and in 
the statistical analysis of the results. It is important that a mechanism for recording repeated sampling 
is introduced and the numbers of sample units repeatedly sampled are included in the report. If this 
information were available, it would allow an analysis considering the intensity of maize MON 810 
cultivation and the possible changes in monitoring characteristic assessment as maize MON 810 
cultivation is repeated in consecutive years. 
Statistical analysis 
1)  Objective and hypotheses 
Appendix 1 states: ‘The aim of the survey is to identify potential adverse effects that might be related 
to MON 810 plants and their cultivation. For that reason, most questions are formulated to get 
ordinary data, i.e. with three possible answers (Plus/ As usual/ Minus). The Plus- and Minus-answers 
indicate a deviation from the situation with conventional maize and are provided with a specification 
to describe the specific effect and its potential cause. High frequency (> 10 %) of Plus or Minus-
answers would indicate possible effects’. 
2)  Statistical analysis plan 
Section 2.4 of Appendix 1 describes the statistical test procedure. The effect is defined as: ‘An effect of 
the cultivation of MON 810 or any other influencing factor would arise in a greater percentage of 
Plus or Minus answers, where "greater" or an effect, was quantitatively defined by exceeding a 
threshold of 10%’ It would be expedient to provide scientific references to support the selection of the 
10 % threshold. Additionally, for certain responses, 10 % may be greater than the acceptable limit of 
change. Alternative statistical analyses allowing the exploration of different effect sizes for certain 
monitoring characteristics would assist in the interpretation of the results. The null hypothesis is that 
the proportion of responses not ´as usual´ is equal to or above 10 %. A significance level of 0.01 % 
was used in the statistical test. If p < 0.01, then the null hypothesis that the minus/plus response is 
equal to or greater than 10 % is rejected and therefore no effect can be identified. 
3)  Pre-defined subgroups 
The analysis was performed for all fields surveyed in 2012. There was no analysis of country level 
data. Given the number of farmers surveyed in some countries, analyses of country-level subgroup 
may not have been statistically valid; however, consideration should be given to the fact that Member 
States may require country-level results. Moreover, in the report it is mentioned: ‘Sampling therefore 
takes place within strata (defined by years and countries of cultivation)’. This stratified sampling 
should also be taken into consideration in the statistical analysis, which currently considers the sample 
as ‘homogeneous’ being comprised of independent units (farmers). In addition, analysis of the 
assessment of monitoring characteristics by new farmers compared with farmers with previous 
experience of cultivation of maize MON 810 would be of interest. This could assist in detecting 
residual effects. Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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4)  Statistical analysis 
The reports states that plus responses and minus responses were ´statistically tested by using the exact 
binomial test´. This test is appropriate for the ´same/different´ type of question. However, for 
questions of the ´as usual or worse or better´ type, where there are three outcomes, an analysis using a 
multinomial test should be performed (in this case a trinomial test). Galyean and Wester (2010) used 
simulation methods to generate experimental count data from multinomial distributions in order to 
compare multinomial and binomial proportion methods for analysis. It was concluded that analysing 
multinomial data as a series of binomial proportions increased the survey-wise type I error rate and 
recommended to use a multinomial analysis to test for the distributional difference with a subsequent 
binomial approach used to test for differences in a specific category or to correct for the multiplicity of 
testing. 
5)  Results presentation 
For each monitoring characteristic measured by the survey, a table of the responses was provided with 
percentage and ´valid percentages´ (the proportion of answers excluding missing values) plus, often, a 
bar chart of the frequency of responses. The valid percentages were used in the binomial test. The 
reasoning between the valid percentages in the table of responses and the table of the results of the 
binomial test for different ´treatments/practices´ should be further explained by the applicant in order 
to facilitate interpretation of the results. Moreover, the presentation of a power calculation in situations 
in which the null hypothesis has been rejected is not necessary. 
6)  Descriptive statistics 
Descriptive statistics were provided for the continuous outcome values number of fields, maize area in 
hectares, percentage humus content, sowing date and harvest date. The analysis of the categorical 
values was provided as frequency tables. 
7)  Multiplicity 
A significance level of 0.01 was used, but the issue of multiplicity of testing was not addressed. 
Another major problem is related to the fact that the analysis needs to be pooled after 10 years to 
achieve the statistical power described in the sample size calculations. Each annual report represents 
an interim analysis, and the statistical analysis plan needs to compensate for these interim analyses, 
considering also possible situations in which the same farmer(s) is (are) sampled in more than one 
years. 
8)  Handing missing values 
In the tables two percentages were presented: the ´Percent´, which included missing values, and the 
´Valid percentages´, in which the missing data or the ´Don’t know´ responses were excluded. 
9)  Confidence intervals 
For statistical tests it is standard practice to use confidence intervals, and these were not usually 
included in Appendix 1. In the table summarising the analysis of the monitoring characteristics (e.g. 
Table 3.1 in Appendix 1) the confidence intervals should be included. The inclusion of confidence 
intervals would allow an understanding of the sensitivity of the analysis to the choice threshold. 
10) Post-hoc analysis 
Post-hoc analysis was performed only in situations in which an effect was identified and further 
explanatory analysis was possible using less structured information, e.g. free text collected in the 
questionnaire. Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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Report conclusions 
1)  Report conclusions 
Appendix 1 contains the following conclusions: 
‘2012 data indicates that in comparison to conventional maize plants, MON 810 plants 
• received less insecticides caused by their inherent protection against certain lepidopteran pests, 
• had less incidence of stalk/root lodging caused by the inherent protection against certain 
lepidopteran pests, 
• had a longer time to maturity caused by the absence of pest pressure of certain lepidopteran 
pests, 
• gave a higher yield caused by the better fitness of the plant, 
• were less susceptible to diseases caused by hardly any insect feeding damage, 
• controlled corn borers very well caused by the inherent protection against certain lepidopteran 
pests, and 
• were less susceptible to pests, other than corn borers, especially lepidopteran pests caused 
by the inherent protection against certain lepidopteran pests and the resulting better fitness 
of the plants’. 
2)  Study design 
The study design was appropriate to evaluate whether a set of monitoring characteristics relating to 
plant performance and management practices for maize MON 810 cultivation in the current year of the 
survey differed from a comparator variety by a threshold of 10 %. However there are indications of 
weaknesses in the sampling methodology applied for the survey and as a consequence the possibility 
of selection bias in the survey cannot be excluded. In addition the result of this assessment was very 
much dependent on the selection of an appropriate comparator.  
Certain effects may reach a sufficient magnitude for detection only with repeated cultivation of a GM 
crop, and so amendments to study design and the analysis plan should be considered in order to assess 
the effect of multiple years of GM crop cultivation. Tables 4.1 and 4.2 in Appendix 1 present the 
results from the previous six years and the 2012 results. The inclusion of the pooled results would be 
of interest. 
3)  Substantiation of results 
Fourty-three farmers (17.3 %) indicated that they had changed their insect control practices in the 
maize MON 810 compared to conventional maize in 2012; The report states: ‘The difference arises 
from farmers using less insecticide applications in general’ and ‘as well as from farmers not 
controlling corn borers any more with conventional insecticide applications’. Seventy farmers (28.1 
%) reported a reduction in stalk and root lodging in the maize MON 810 compared with the 
conventional field. A reduction in stalk and root lodging was also observed in the field trial studies. 
Concerning ‘time to maturity’ there is some inconsistency between the number of farmers reporting a 
delayed time to maturity mentioned in the text (32 farmers) and in the tables (40 farmers). The Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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respective statistical test in based on fourty farmers (16.1 %) reporting delayed maturity. Forty-three 
farmers (17.3 %) reported that the maize MON 810 field was less susceptible to diseases, with 
associated reports of reduced susceptibility predominantly to Fusarium spp. (21 farmers) and Ustilago 
maydis (18 farmers). The reports of reduced susceptibility to fungal infections were substantiated with 
similar findings from the scientific literature. Two hundred and twenty-four farmers (valid percentage: 
91.1 %) and 196 farmers (valid percentage 90.7 %) reported that maize MON 810 provided ´very 
good´ control of ECB and pink borer, respectively. These results are to be expected, as the genetic 
modification provides protection from corn borers and therefore should result in a healthier crop. 
Fifty-three farmers (21.3 %) reported maize MON 810 to be less susceptible to pests other than the the 
two borers mentioned above (with associated reports of reduced susceptibility predominantly to pests 
of the orders Lepidoptera and Arachnida). An increased yield was reported by 107 farmers (43 %); as 
maize MON 810 has less insect damage, an increased yield is not unexpected.  
 
For the monitoring characteristics above, the null hypothesis that an effect was evident could not be 
rejected. One farmer (0.4 %) reported an assessment of the MON 810 maize as more susceptible to 
pests other than the the two borers mentioned above (ECB and pink borer) compared to conventional 
maize (however, the corresponding null hypothesis of fmore susceptible ≥ 0.1 could be rejected). while a 
lower yield, in comparison with conventional maize, was reported by 6 farmers (2.4 % - however, the 
corresponding null hypothesis of flower ≥ 0.1 could be rejected). Presenting all results with confidence 
intervals would have facilitated the interpretation of the results and would have allowed the effect of 
the selection of alternative threshold values other than the arbitrarily selected 10 % to be explored. 
The monitoring characteristics that were not ´as usual´ described above were also observed in the 
2011 PMEM reports. In 2012, not ´as usual´ responses above the 10  % threshold related to the 
occurrence of volunteers were not observed. The consistency of the results in each year of survey 
indicates the stability of the observed effects. Interpretation of the results should be viewed with 
caution as there are indications of weaknesses in the sampling methodology applied for the survey and 
as a consequence the possibility of selection bias in the survey cannot be excluded. It is important that 
an appropriate and consistent sampling methodology is used. The grouping of sample units according 
to the strata and random selection of sample units from within the strata should be performed using the 
specified sampling frame prior to conducting the interviews. A description of the method to ensure 
that units are randomly selected from the sampling frame should be included in the report, including, 
where relevant, the statistical software and/or the program code used for this procedure. The 
proportion of new farmers and farmers with previous experience of maize MON 810 selected from the 
sampling frame for each region should be presented in the report to provide evidence that the sampling 
method ensures that areas of intensive maize MON 810 cultivation are appropriately covered in the 
survey. 
Recommendations and Conclusions 
From the data provided in the 2012 farmer’s survey to monitor adverse effects associated with the 
cultivation of maize MON 810, no adverse effect can be identified. However the 2012 report provides 
limited information on the sampling methodology and the possibility of selection bias in the survey 
cannot be excluded. Therefore, the following improvements to the survey design and reporting are 
recommended: 
-  Full details on the source of the sampling frame, the number of farmers and the major 
characteristics (e.g. previous cultivation of maize MON 810) of the farmers should be 
included in the survey report. The national registers set by Member States for the cultivation 
of GM crops would be the optimum sampling frame, if available. 
-  A full description of the method by which the number of farmers to be monitored per year and 
country is determined, should be provided. It is currently, indicated that this is based on two 
subdivision factors, however, inadequate clarification is given on how this is actually done.   Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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-  A description of the method to ensure that units are randomly selected from the sampling 
frame should be included in the report, including, where relevant, the statistical software 
and/or the program code used for this procedure. The proportion of new farmers and farmers 
with previous experience of maize MON 810 selected from the sampling frame for each 
region should be presented in the monitoring report to provide evidence that the sampling 
method ensures that areas of intensive maize MON 810 cultivation are appropriately covered 
by the survey. 
-  The losses to sampling should be fully documented in the report to provide evidence that there 
is no non-response bias. It is important to know if a specific subgroup of farmers is not 
participating in the survey and therefore is not represented in the survey findings; 
-  It is recommended that independent trained interviewers are used to reduce interviewer bias. It 
is also recommended that the interviews are conducted in the same way for all participating 
farmers, for example either by telephone or by personal interview. In cases that this is not 
possible, additional attention should be given to the uniformity of the delivery of the questions 
and the achievement of results of comparable quality.  
-  It is recommended that the farmer questionnaire contains questions to record whether the 
comparator field is growing on the same farm in the same growing season and the variety of 
the comparator. If no comparators are being grown spatially or temporally close to the GM 
crop, then the rationale for selecting another comparator (e.g. maize grown in previous years) 
should be fully described. The comparators selected by the farmers for the survey should be 
summarised in the PMEM report. 
-  Farmer questionnaires should focus only on changes that would be recognised by the farmer 
during the daily management of the farm. However, additional questions could be included to 
gain a better understanding of the intensity of GM maize cultivation on the farm (number of 
years of maize MON 810 cultivation and frequency of maize MON 810 in crop rotations), and 
further information on plant protection product usage (in particular, in the comparator field) 
should be obtained to facilitate a full understanding of any observed changes. Moreover, 
qualitative responses may sometimes relate to a subjective assessment on the part of the 
farmer. An effort should be made to use objective measurable outcomes, whenever this is 
possible.   
-  Confidence intervals for the analysis of the monitoring characteristics should be included in 
the statistical report. Presenting all results with confidence intervals would have facilitated 
their interpretation and allowed the effect of the selection of alternative threshold values other 
than the arbitrarily selected 10 % to be explored. The choice of statistical test should be based 
on the number of possible outcomes, the use of a series of binomial tests for multinomial 
distributions would increase the experiment-wise type I error rate (i.e. failure to detect a true 
adverse effect). 
-  The statistical analysis should be planned to allow an analysis of the monitoring 
characteristics according to the length of GM crop cultivation in order to assess residual 
effects. As the statistical power of the study will be achieved only after 10 years, this will 
require a pooled analysis. Consequently, when conducting the survey, consideration should be 
given to the consistency of questions to assess monitoring characteristics, the inclusion of the 
same farmers in consecutive years in the survey (and the enumeration of these farmers in the 
report) and the interim analyses performed for the annual reports.  
-  In situations in which there are three outcomes (of the type: ´as usual’ or ‘worse’ or ‘better´), 
it is recommended to use a more appropriate multinomial analysis to test for the distributional 
difference, with a subsequent binomial approach used to test for differences in a specific Scientific Opinion on 2012 Monsanto PMEM report on GM maize MON 810 
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category or to correct for the multiplicity of testing. Statistical analysis should also account for 
the stratified nature of the sample.  
-  The presentation of the results reported in Appendix 1 of the 2012 PMEM report should be 
improved in order to facilitate their interpretation. 
 